drugset / Trial / NCT00196534

A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery

NCT00196534

Phase 3 Completed 304 enrolled Ethicon, Inc. OMRIX Biopharmaceuticals · collab
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to see if Human Thrombin is as effective as Bovine Thrombin in stopping surgical bleeding within 10 minutes of application.

Timeline

Start
2004-11
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bovine Thrombin Protein / enzyme biologic Topical
Subject Human Thrombin Protein / enzyme biologic Topical

Indications

No indication recorded.